Journey Medical Corp
Journey Medical Corp (DERM) Covered Calls
As of September 25, 2026, DERM has 3 covered call opportunities in the coming three months. Return ranges from 23.8 to 63.7% until expiration. Annualized return ranges from 71.2 to 158.1%. The nearest expiration is November 20, 2026. Maximum potential profit is $391.
Read more
Running DERM covered calls helps you generate consistent income from Journey Medical Corp's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Journey Medical Corp involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best DERM covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if DERM stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling DERM covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Journey Medical Corp covered call is worth writing.
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution.
The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Income-focused investors, long-term DERM holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling DERM covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Journey Medical Corp covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV percentile—
- Market cap (M$)173
- 52 weeks high-35.77%
- 52 weeks low42.46%
- Analyst recommendationStrong Buy
1.00 - Target price$13.75
123.94% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E9.06
- EPS (ttm)-0.23
- EPS growth next 5 years—
As of September 25, 2026
| 2027-02-19 | 147 | 10.00 | 62.87 | 0.05 | 0.45 | 391.00 | 63.68 | 158.12 | -0.81 | +0.20 | 119 | 0.40 |
| 2026-11-20 | 56 | 7.50 | 22.15 | 0.10 | 0.45 | 146.00 | 23.78 | 154.98 | -1.63 | +0.29 | 187 | 0.35 |
| 2027-02-19 | 147 | 7.50 | 22.15 | 0.40 | 0.80 | 176.00 | 28.66 | 71.17 | -6.51 | +0.41 | 937 | 0.40 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best DERM covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→